SCHEMBL9350776

SCHEMBL9350776

CC(=O)Cn1cnc2[nH]c(=O)n(CC3CC3)c(=O)c21

nearest known ligand 0.43

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.43
PDE4B Q07343 2/20 0.43
PDE4C Q08493 2/20 0.43
PDE4D Q08499 2/20 0.43
ADORA2A P29274 1/20 0.43
ADORA2B P29275 1/20 0.43
CNOT7 Q9UIV1 8/20 0.41
PARN O95453 1/20 0.41
GRIN1 Q05586 3/20 0.41
GRIN2B Q13224 3/20 0.41
LMNA P02545 1/20 0.40
TRPA1 O75762 1/20 0.40
JAK2 O60674 1/20 0.37
JAK1 P23458 1/20 0.37
JAK3 P52333 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9350658 0.88 CNOT7 (0.43) PDE4APDE4BPDE4CPDE4DCNOT7
SCHEMBL27537551 0.82 GRIN1 (0.43) CNOT7PARNGRIN1GRIN2B
SCHEMBL10694966 0.81 PDE4A (0.48) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL17682308 0.81 CNOT7 (0.39) CNOT7PARNGRIN1GRIN2BLMNA
SCHEMBL17682309 0.81 CNOT7 (0.39) CNOT7PARNGRIN1GRIN2BLMNA
SCHEMBL7403404 0.80 ALDH1A1 (0.57) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL10696644 0.80 ADORA2B (0.65) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL11078954 0.80 ADORA2B (0.48) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL21861597 0.79 TRPA1 (0.59) PDE4APDE4BPDE4CPDE4DADORA2A
SCHEMBL10696193 0.79 PDE4A (0.46) PDE4APDE4BPDE4CPDE4DADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0369744-B1 Xanthine derivatives, process for their preparation and pharmaceutical compositions SMITHKLINE BEECHAM PHARMA GMBH (DE) 1994-09-21 EP disclosed
US-5321029-A Vascular and skin disorders; bronchodilator BEECHAM-WUELFING GMBH & CO.K.G. (DE) 1994-06-14 US disclosed
EP-0369744-A2 Xanthine derivatives, process for their preparation and pharmaceutical compositions SMITHKLINE BEECHAM PHARMA GmbH (DE) 1990-05-23 EP disclosed